Science
Sarah Silbiger/Getty Images
FDA Approves Alzheimer’s Drug Amid Doubts Over Efficacy
GIVING IT A SHOT
The agency “will continue to monitor Aduhelm as it reaches the market and ultimately the patient’s bedside,” it said in a news release.

Trending Now